Lifibrol as a model compound for a novel lipid-lowering mechanism of action

Lifibrol is a potent lipid-lowering drug with an unknown mechanism of action. We investigated its effects on lipoprotein and sterol metabolism in normocholesterolemic male participants. Seven participants were treated for 4 weeks with 600 mg/d lifibrol and 9 with 40 mg/d pravastatin in a double-blin...

Full description

Bibliographic Details
Published in:Journal of cardiovascular pharmacology and therapeutics, Vol. 15, No. 4 (2010), p. 364-72
Main Author: Berthold, Heiner K
Other Involved Persons: Sudhop, Thomas ; von Bergmann, Klaus ; Gouni-Berthold, Ioanna
Format: electronic Article
Language:English
ISSN:1940-4034
Item Description:Date Completed 03.03.2011
Date Revised 20.11.2014
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
DOI:10.1177/1074248410371100
Subjects:
QR Code: Show QR Code